|03-19-2019 09:57 AM CET - Health & Medicine||
Neurological Biomarkers Market Foreseen to Grow Exponentially Over 2018-2025
Press release from: Allied Market Research
According to a new report published by Allied Market Research, titled, Customized Study on Neurological Biomarkers Market for Alzheimers and Parkinsons Disease: Global Opportunity Analysis and Industry Forecast, 2017-2025, the global market was valued at $3,958.5 million in 2017, and is projected to reach $8,579.9 million by 2025, growing at a CAGR of 10.1% from 2018 to 2025. China accounted for one-ninth share of the total market of neurological biomarkers for Alzheimers in 2017.
The major companies profiled in this report include Abbott Laboratories, Myriad RBM, Proteome Sciences, Thermo Fisher Scientific, Athena Diagnostics, Immunarray Pvt. Ltd.,
Quanterix Corporation, Diagenic ASA, Psynova Neurotech, and Bio-Rad Laboratories. Other prominent players in the value chain include Qiagen, AbaStar MDx, Acumen Pharmaceuticals, Abiant, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, and ProteoSys AG.
Increase in demand for noninvasive neurological biomarkers is expected to supplement the market growth. Furthermore, rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer‐™s and Parkinson‐™s diseases is expected to drive the market growth in the near future. For instance, MSDx, Inc. is developing cost-effective and reliable blood-based neurological biomarkers that can aid in detecting the onset of disease before excessive damage occurs. The company has patented the blood test and has named it as the ‐Window into The Brain
Download Sample PDF Brochure of Neurological Biomarkers Market at: www.alliedmarketresearch.com/request-sample/3555
The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, and is expected to reach $6,122.5 million by 2025, registering a CAGR of 11.1% from 2018 to 2025. Conversely, neurological biomarkers market for Parkinsons disease generated a revenue of $1,321.8 million in 2017, and is expected to reach $2,457.4 million by 2025 registering a CAGR of 8.0%.
Upsurge in the incidence of Alzheimers and Parkinsons diseases is anticipated to contribute to the robust growth of neurological biomarkers. In addition, increase in adoption of neurological biomarkers in drug development and validation has been witnessed over the years to improve the accuracy of clinical trials. Furthermore, rise in preference towards personalized medicine is expected to offer profitable opportunities for the expansion of neurological biomarkers applied across Alzheimers and Parkinsons.
Based on the region, the neurological biomarkers market for Alzheimers and Parkinsons diseases is studied across the U.S., EU5, rest of Europe, China, Asia-Pacific, and rest of the world (ROW). The U.S. dominated the market for Alzheimers and Parkinsons in 2017, and is expected to continue this trend throughout the forecast period. In addition, Asia-Pacific is anticipated to grow at the fastest pace in Alzheimers neurological biomarkers market during the forecast period, whereas China is expected to register highest growth rate from 2018 to 2025 in the Parkinsons neurological biomarkers market.
Buy Now at: www.alliedmarketresearch.com/checkout/574473
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
News-ID: 1661463 • Views: 434More releases